SSRI versus bupropion effects on symptom clusters in suicidal depression: Post hoc analysis of a randomized clinical trial

Journal of Clinical Psychiatry

Volumn 74, Issue 9, 2013, Pages 872-879

  Grunebaum, Michael F ^a   Keilp, John G ^a   Ellis, Steven P ^a   Sudol, Katherin ^a   Bauer, Neal ^a   Burke, Ainsley K ^a   Oquendo, Maria A ^a   Mann, J John ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED RELEASE FORMULATION; DEPRESSION; DRUG DOSE INCREASE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUICIDAL IDEATION; SUICIDE ATTEMPT;

EID: 84884807141     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.12m08000     Document Type: Article

References (58)

1. Mann JJ, Apter A, Bertolote J, et al. Suicide prevention strategies: a systematic review. JAMA. 2005;294(16):2064-2074. doi:10.101/jama.294.16.2064 PubMed
2. Knox KL, Caine ED. Establishing priorities for reducing suicide and its antecedents in the United States. Am J Public Health. 2005;95(11):1898-1903. doi:10.2105/AJPH.204.047217 PubMed
3. The cost of violence in the United States. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention Website. www.cdc. gov. Accessed January 16, 2013.
4. Corso PS, Mercy JA, Simon TR, et al. Medical costs and productivity losses due to interpersonal and self-directed violence in the United States. Am J Prev Med. 2007;32(6):474-482. doi:10.1016/j.amepre.207.02.010 PubMed
5. Mental health: suicide prevention and special programmes; country reports and charts available. World Health Organization Website. http://www.who. int/mental-health/prevention/suicide/country-reports/en/. Accessed January 23, 2013.
6. Nock MK, Hwang I, Sampson NA, et al. Mental disorders, comorbidity and suicidal behavior: results from the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(8):868-876. PubMed
7. Kessler RC, Borges G, Walters EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry. 1999;56(7):617-626. doi:10.101/archpsyc.56.7.617 PubMed
8. Oquendo MA, Galfalvy HC, Russo S, et al. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry. 2004;161(8): 1433-1441. doi:10.176/api.ajp.161.8.143 PubMed
9. Fawcett J, Scheftner WA, Fogg L, et al. Time-related predictors of suicide in major affective disorder. Am J Psychiatry. 1990;147(9):1189-1194. PubMed
10. Gibbons RD, Brown CH, Hur K, et al. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry. 2012;69(6): 580-587. doi:10.101/archgenpsychiatry.201.2048 PubMed
11. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56 PubMed
12. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4(6):561-571. doi:10.101/archpsyc.1961. 017101203104 PubMed
13. Mann JJ, Waternaux C, Haas GL, et al. Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry. 1999;156(2):181-189. PubMed
14. Mann JJ, Malone KM. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Biol Psychiatry. 1997;41(2):162-171. doi:10.1016/S06-323(96)0217-X PubMed
15. Van Gastel A, Schotte C, Maes M. The prediction of suicidal intent in depressed patients. Acta Psychiatr Scand. 1997;96(4):254-259. doi:10.1/j.160-047.197.tb10160.x PubMed
16. Gibbons RD, Clark DC, Kupfer DJ. Exactly what does the Hamilton Depression Rating Scale measure? J Psychiatr Res 1993;27(3): 259-273. doi:10.1016/02-3956(93)9037-3 PubMed
17. Bagby RM, Ryder AG, Schuller DR, et al. The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry 2004; 161(12):2163-2177. doi:10.176/api.ajp.161.12.2163 PubMed
18. Steer RA, Beck AT, Riskind JH, et al. Relationships between the Beck Depression Inventory and the Hamilton Psychiatric Rating Scale for Depression in depressed outpatients. J Psychopathol Behav Assess. 1987; 9(3):327-339. doi:10.107/BF0964561
19. Gullion CM, Rush AJ. Toward a generalizable model of symptoms in major depressive disorder. Biol Psychiatry. 1998;44(10):959-972. doi:10.1016/S06- 323(98)0235-2 PubMed
20. DiMascio A, Weissman MM, Prusoff BA, et al. Differential symptom reduction by drugs and psychotherapy in acute depression. Arch Gen Psychiatry. 1979;36(13):1450-1456. doi:10.101/archpsyc.1979.017801306808 PubMed
21. Bruijn JA, Moleman P, Mulder PGH, et al. Depressed in-patients respond differently to imipramine and mirtazapine. Pharmacopsychiatry. 1999; 32(3):87-92. doi:10.105/s-207-97920 PubMed
22. Feighner JP, Overo K. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression. J Clin Psychiatry. 1999;60(12): 824-830. doi:10.408/JCP.v60n1204 PubMed
23. Jamerson BD, Krishnan KR, Roberts J, et al. Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression. Psychopharmacol Bull. 2003;37(2):67-78. PubMed
24. Trivedi MH, Morris DW, Grannemann BD, et al. Symptom clusters as predictors of late response to antidepressant treatment. J Clin Psychiatry. 2005;66(8):1064-1070. doi:10.408/JCP.v6n0816 PubMed
25. Stewart JG, Harkness KL. Symptom specificity in the acute treatment of Major Depressive Disorder: a re-analysis of the treatment of depression collaborative research program. J Affect Disord. 2012;137(1-3):87-97. doi:10.1016/j.jad.201.12.015 PubMed
26. Grunebaum MF, Keilp J, Li S, et al. Symptom components of standard depression scales and past suicidal behavior. J Affect Disord. 2005;87(1): 73-82. doi:10.1016/j.jad.205.03.02 PubMed
27. Lester D, Beck AT. Suicidal wishes and depression in suicidal ideators: a comparison with attempted suicides. J Clin Psychol. 1977;33(1):92-94. doi:10.102/1097-4679(19701)3:1+<92:AID-JCLP2703018>3.0.CO;2-S PubMed
28. Brown C, Schulberg HC, Madonia MJ. Assessing depression in primary care practice with the Beck Depression Inventory and the Hamilton Rating Scale for Depression. Psychol Assess. 1995;7(1):59-65. doi:10.1037/1040-3590.7.1.59
29. Sayer NA, Sackeim HA, Moeller JR, et al. The relations between observerrating and self-report of depressive symptomatology. Psychol Assess. 1993; 5(3):350-360. doi:10.1037/1040-3590.5.3.350
30. Rhoades HM, Overall JE. The Hamilton Depression Scale: factor scoring and profile classification. Psychopharmacol Bull. 1983;19:91-96.
31. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol. 1979;47(2):343-352. doi:10.1037/02-06X.47.2.343 PubMed
32. Keilp JG, Grunebaum MF, Gorlyn M, et al. Suicidal ideation and the subjective aspects of depression. J Affect Disord. 2012;140(1):75-81. doi:10.1016/j.jad.2012.01.045 PubMed
33. Grunebaum MF, Ellis SP, Duan N, et al. Pilot randomized clinical trial of an SSRI vs bupropion: effects on suicidal behavior, ideation, and mood in major depression. Neuropsychopharmacology. 2012;37(3):697-706. doi:10.1038/np.201.247 PubMed
34. Baldessarini RJ. Drug therapy of depression and anxiety disorders. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics 11th edition. New York, NY: McGraw-Hill; 2006:429-459
35. Spitzer RL, Williams JBW, Gibbon M, et al. Structured Clinical Interview for DSM-III-R/DSM-IV Patient edition (SCID-P). Washington, DC: American Psychiatric Press; 1990.
36. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II), (Version 2.0). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1996.
37. Oquendo MA, Halberstam B, Mann JJ. Risk Factors for Suicidal Behavior: utility and limitations of research instruments. In: First MB, ed. Standardized Evaluation in Clinical Practice. Vol 22. Washington, DC: APPI Press; 2003:103-130.
38. Gueorguieva R, Krystal JH. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry. 2004;61(3)310-317 doi:10.101/archpsyc. 61.3.310 PubMed
39. Beck AT, Lester D, Albert N. Suicidal wishes and symptoms of depression. Psychol Rep. 1973;33(3):770. doi:10.246/pr0.1973.3.3.70 PubMed
40. Grunebaum MF, Galfalvy HC, Oquendo MA, et al. Melancholia and the probability and lethality of suicide attempts. Br J Psychiatry. 2004;184(6): 534-535. doi:10.192/bjp.184.6.534 PubMed
41. McCall WV, Blocker JN, D'Agostino R Jr, et al. Insomnia severity is an indicator of suicidal ideation during a depression clinical trial. Sleep Med. 2010;11(9):822-827. doi:10.1016/j.slep.2010.04.04 PubMed
42. Goldstein TR, Bridge JA, Brent DA. Sleep disturbance preceding completed suicide in adolescents. J Consult Clin Psychol. 2008;76(1):84-91. doi:10.1037/02-06X.76.1.84 PubMed
43. Rudd MD, Berman AL, Joiner TEJ Jr, et al. Warning signs for suicide: theory, research, and clinical applications. Suicide Life Threat Behav. 2006;36(3):255-262. doi:10.1521/suli.206.36.3.25 PubMed
44. Bjorngaard JH, Bjerkeset O, Romundstad P, et al. Sleeping problems and suicide in 75,000 Norwegian adults: a 20 year follow-up of the HUNT I study. Sleep. 2011;34(9):1155-1159. PubMed
45. Milak MS, Parsey RV, Keilp J, et al. Neuroanatomic correlates of psychopathologic components of major depressive disorder. Arch Gen Psychiatry. 2005;62(4):397-408. doi:10.101/archpsyc.62.4.397 PubMed
46. Weissman MM, Klerman GL, Markowitz JS, et al. Suicidal ideation and suicide attempts in panic disorder and attacks. N Engl J Med. 1989;321(18): 1209-1214. doi:10.1056/NEJM1989102321801 PubMed
47. Johnson J, Weissman MM, Klerman GL. Panic disorder, comorbidity, and suicide attempts. Arch Gen Psychiatry. 1990;47(9):805-808. doi:10.101/archpsyc. 190.018102101302 PubMed
48. Friedman S, Jones JC, Chernen L, et al. Suicidal ideation and suicide attempts among patients with panic disorder: a survey of two outpatient clinics. Am J Psychiatry. 1992;149(5):680-685. PubMed
49. Lepine JP, Chignon JM, Teherani M. Suicide attempts in patients with panic disorder. Arch Gen Psychiatry. 1993;50(2):144-149. doi:10.101/archpsyc. 193.01820140708 PubMed
50. Hornig CD, McNally RJ. Panic disorder and suicide attempt: a reanalysis of data from the Epidemiologic Catchment Area study. Br J Psychiatry. 1995;167(1):76-79. doi:10.192/bjp.167.1.76 PubMed
51. Roy-Byrne PP, Stang P, Wittchen HU, et al. Lifetime panic-depression comorbidity in the National Comorbidity Survey: association with symptoms, impairment, course and help-seeking. Br J Psychiatry. 2000;176(3):229-235. doi:10.192/bjp.176.3.29 PubMed
52. Apter A, Horesh N, Gothelf D, et al. Depression and suicidal behavior in adolescent inpatients with obsessive compulsive disorder. J Affect Disord. 2003;75(2):181-189. doi:10.1016/S0165-0327(02)038-1 PubMed
53. Vickers K, McNally RJ. Panic disorder and suicide attempt in the National Comorbidity Survey. J Abnorm Psychol. 2004;113(4):582-591. doi:10.1037/021- 843X.13.4.582 PubMed
54. Placidi GPA, Oquendo MA, Malone KM, et al. Anxiety in major depression: relationship to suicide attempts. Am J Psychiatry. 2000;157(10):1614-1618. doi:10.176/api.ajp.157.10.1614 PubMed
55. Trivedi MH, Pigotti TA, Perera P, et al. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder. J Clin Psychiatry. 2004;65(10):1356-1364. doi:10.408/JCP.v65n1010 PubMed
56. Reimherr FW, Cunningham LA, Batey SR, et al. A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients. Clin Ther. 1998;20(3): 505-516. doi:10.1016/S0149-2918(98)8060-X PubMed
57. Papakostas GI, Fava M. Does the probability of receiving placebo influence clinical trial outcome? a meta-regression of double-blind, randomized clinical trials in MDD. Eur Neuropsychopharmacol. 2009;19(1):34-40. doi:10.1016/j.euroneuro.208.08.09 PubMed
58. van der Lem R, van der Wee NJA, van Veen T, et al. Efficacy versus effectiveness: a direct comparison of the outcome of treatment for mild to moderate depression in randomized controlled trials and daily practice. Psychother Psychosom. 2012;81(4):226-234. doi:10.159/030890 PubMed